Ammar Hashmi, MD
Vascular Surgery · Houston, TXNPI 1871903492
Payments from drug & device makers
Across 109 payments — averaging $49.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- W. L. Gore & Associates, Inc.$311
- Boston Scientific$294
- Bard Peripheral Vascular, Inc.$252
- Baxter Healthcare$188
- Inari Medical, Inc.$183
- plus $2K from 30 others
What the payments were for
- Travel & lodging$89716%
- Food & beverage$3,73469%
- Education$80515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 20 | $2,286 |
| W. L. Gore & Associates, Inc. | 3 | $311 |
| Boston Scientific | 7 | $294 |
| Bard Peripheral Vascular, Inc. | 15 | $252 |
| Baxter Healthcare | 2 | $188 |
| Inari Medical, Inc. | 2 | $183 |
| Bone Support Inc. | 1 | $153 |
| Cook Medical LLC | 4 | $148 |
| Surmodics, Inc. | 4 | $126 |
| Acera Surgical, Inc. | 3 | $126 |
| Lemaitre Vascular, Inc. | 5 | $116 |
| Endologix LLC | 2 | $116 |
| Cvrx, Inc. | 2 | $115 |
| Penumbra, Inc. | 2 | $106 |
| Johnson & Johnson | 5 | $106 |
| Mindray DS USA, Inc. | 2 | $94 |
| Shockwave Medical, Inc | 4 | $90 |
| Aroa Biosurgery Incorporated | 2 | $66 |
| Bolton Medical Inc | 3 | $65 |
| Solventum Corporation | 3 | $56 |
| Silk Road Medical, Inc. | 2 | $56 |
| Tactile Systems Technology Inc | 2 | $45 |
| Abiomed | 1 | $45 |
| BD | 1 | $41 |
| Octapharma USA, Inc. | 1 | $31 |
| Livanova USA, Inc. | 1 | $29 |
| Edwards Lifesciences | 1 | $25 |
| Argon Medical Devices, Inc. | 1 | $23 |
| Enablecv Inc. | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Dilon Technologies, Inc. | 1 | $20 |
| Veryan Medical Incorporated | 1 | $20 |
| Cagent Vascular Inc | 1 | $19 |
| Ossur Americas, Inc. | 1 | $18 |
| On Target Laboratories, Inc | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,436 in reported general payments places this provider in the 35th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 16 | $121 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Houston
- Alan LumsdenHouston$2.4M
- Gustavo OderichHouston$999K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
- Jean BismuthHouston$382K
- Kristofer Charlton-OuwHouston$240K
- Maham RahimiHouston$221K
- Jayer ChungHouston$179K
- Steven MaximusHouston$140K
- Charudatta BavareHouston$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.